Mitochondrial hyperactivity as a potential therapeutic target in Parkinson's disease
{{output}}
Mitochondrial dysfunction is thought to contribute to neurodegeneration in Parkinson's disease (PD), yet the cellular events that lead to mitochondrial disruption remain unclear. Post-mortem studies of PD patient brains and the use of complex I inhibitors to m... ...
